Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.

Autor: Frucht, Harold, Howard, John M., Staff, James I., Wank, Steven A., McCarthy, Dennis M., Maton, Paul N., Vinayek, Rakesh, Gardner, Jerry D., Jensen, Robert T., Frucht, H, Howard, J M, Slaff, J I, Wank, S A, McCarthy, D M, Maton, P N, Vinayek, R, Gardner, J D, Jensen, R T
Předmět:
Zdroj: Annals of Internal Medicine; 11/1/89, Vol. 111 Issue 9, p713-722, 10p
Abstrakt: Study Objective: To evaluate criteria of positivity for and usefulness of both the secretin and calcium gastrin-provocative tests in patients with the Zollinger-Ellison syndrome.Design: Prospective trial in consecutive patients.Setting: Referrals to a clinical research center.Patients: Consecutive sample of 80 patients with the Zollinger-Ellison syndrome.Intervention: Kabi-secretin (2 U/kg body weight) given by intravenous bolus and calcium gluconate (10%) (54 mg/kg.h [5 mg/kg.h of calcium]) given by continuous intravenous infusion for 3 hours. Serum gastrin measured at -15, and -1 minutes before, and 2, 5, 10, 15, 20, and 30 minutes after secretin, or every 30 minutes for 3 hours during the calcium infusion. Serum calcium and serum gastrin were measured simultaneously during the calcium infusion.Measurements and Main Results: There was no significant difference in the responses of patients with different extents or locations of the tumor, presence or absence of multiple endocrine neoplasia, type-I, or with fasting gastrin less than or greater than 1000 pg/mL. In patients with fasting gastrin of less than 1000 pg/mL, the sensitivity of the secretin test using the criterion of an increase in gastrin of at least 110 pg/mL was 93% (CI, 76% to 99%) and for an increase of 200 pg/mL it was 85% (CI, 66% to 96%), (P greater than 0.05). With the calcium infusion test, the sensitivity using the criterion of an increase of 395 pg/mL was 43%, (CI, 23% to 66%) and for an increase of 50% was 74% (CI, 52% to 90%), (P less than 0.01). The calcium infusion test was positive in 33% of patients with a negative secretin test. With the secretin test, 75% of patients had a positive response by 5 minutes, 95% by 10 minutes, 100% by 15 minutes, and 6% only at 2 minutes. With calcium infusion, patients had positive responses at 120 to 180 minutes.Conclusions: The secretin test is preferred over the calcium test because of its greater sensitivity and simplicity. The recommended criteria are a 200 pg/mL increase for the secretin test and a 395 pg/mL increase for the calcium test. The calcium test should be reserved for patients having a negative secretin test, gastric acid hypersecretion, and a strong clinical suspicion of the Zollinger-Ellison syndrome. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index